骨髓纤维化
医学
疾病
叙述性评论
流行病学
骨髓
临床表型
骨髓增生性疾病
外周血
重症监护医学
临床实习
生物信息学
病理
表型
内科学
家庭医学
生物
遗传学
基因
作者
Massimo Breccia,Francesca Palandri,Nicola Polverelli,Morena Caira,Michela Berluti,Giuseppe A. Palumbo,Valerio De Stefano
标识
DOI:10.3389/fonc.2024.1382872
摘要
Myelofibrosis (MF) is a clonal disorder of hematopoietic stem cells characterized by altered bone marrow function and fibrosis. The aim of this narrative review is to report on the most recent epidemiologic data and to discuss features of MF and current strategies for the management of this condition in clinical practice. MF features covered by our review will include: characteristics of patients with MF; myeloproliferative and myelodepletive phenotypes; MF-associated thrombosis and bleeding; risk of infections; prefibrotic and overt PMF; secondary MF. Finally, we will discuss a few aspects of MF management in clinical practice and suggest strategies for its optimization and standardization. The focus of our paper is on Italy, but relevant data from other countries will also be reviewed.
科研通智能强力驱动
Strongly Powered by AbleSci AI